Search
forResearch 10 of 1000+
- Trypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid Transporters in Trypanosoma cruzi
- Entrepreneurship in Off-Label Drug Prescription: Just What the Doctor Ordered!
- High-content drug screening for rare diseases
- The Necessity to Investigate In Vivo Fate of Nanoparticle-Loaded Dissolving Microneedles
- Microneedles: Selected Applications for Pediatrics
- Controversies in off‐label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies
- Response of Hemiballismus to Haloperidol-Reply
- SYNERGIA AI I MEDYCYNY: SZANSE I WYZWANIA
- Spotlight Commentary: Importance of dose redefining in the process of drug repurposing
- Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products
Community 4 of 117
- Pelage are going to do two phase 3 trials for PP405. How long will it take to complete two phase 3 trials?
- 12M post-op +dutasteride daily / FUE 3000Hairs in Korea
- US FDA will now default to only one clinical trial for drug applications, will this accelerate the release of PP405 and other drugs in clinical trials?
- FDA Policy Shift Explained: What It Actually Means for PP405, VDPHL-01, Breezula and Hair Loss Drug Timelines